Avaliação da qualidade de cápsulas de Coenzima Q10 comercializada no mercado brasileiro

Abstract

Currently, coenzyme Q10 (CoQ10) has been the focus of studies and has shown beneficial results for health. The production of encapsulated dietary supplements follows less stringent quality criteria, making it easier for them to enter the market without strict control from ANVISA (National Health Surveillance Agency). However, for consumers, these products are more than supplements; they often represent an alternative for treatment or prophylaxis. This study aimed to evaluate the quality of CoQ10-containing capsules, obtained through online platforms and local commerce (Campo Grande-MS), from the perspective of physicochemical parameters: average weight, disintegration, thin-layer chromatography, and content. The results showed that out of the 10 samples analyzed, 90% did not meet the expected parameters, and 30% did not contain the active substance in the formulation. Urgent action by public authorities is necessary, as these formulations can pose serious risks to public health, leading to financial losses and potentially causing a lack of expected effects and, in some cases, death.